These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 20364755)
1. In vitro activity of linezolid against clinical isolates of methicillin resistant Staphylococcus. Hannan A; Absar M; Usman M; Naeem T; Saleem S; Arshad M J Ayub Med Coll Abbottabad; 2009; 21(1):106-9. PubMed ID: 20364755 [TBL] [Abstract][Full Text] [Related]
2. [In vitro susceptibility to linezolid in methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus strains]. Efe S; Sinirtaş M; Ozakin C Mikrobiyol Bul; 2009 Oct; 43(4):639-43. PubMed ID: 20084917 [TBL] [Abstract][Full Text] [Related]
3. In vitro pharmacokinetic/pharmacodynamic activity of NXL103 versus clindamycin and linezolid against clinical Staphylococcus aureus and Streptococcus pyogenes isolates. Vidaillac C; Parra-Ruiz J; Winterfield P; Rybak MJ Int J Antimicrob Agents; 2011 Oct; 38(4):301-6. PubMed ID: 21764263 [TBL] [Abstract][Full Text] [Related]
4. Comparative activity of telavancin and other antimicrobial agents against methicillin-resistant Staphylococcus aureus isolates collected from 1991 to 2006. Shams W; Walker ES; Levy F; Reynolds SA; Peterson SM; Sarubbi FA Chemotherapy; 2010; 56(5):411-6. PubMed ID: 20948212 [TBL] [Abstract][Full Text] [Related]
5. Activity of fusidic acid against extracellular and intracellular Staphylococcus aureus: influence of pH and comparison with linezolid and clindamycin. Lemaire S; Van Bambeke F; Pierard D; Appelbaum PC; Tulkens PM Clin Infect Dis; 2011 Jun; 52 Suppl 7():S493-503. PubMed ID: 21546626 [TBL] [Abstract][Full Text] [Related]
6. Comparison of in vitro efficacy of linezolid and vancomycin by determining their minimum inhibitory concentrations against methicillin resistant Staphylococcus aureus (MRSA). Kaleem F; Usman J; Khalid A; Hassan A; Omair M J Pak Med Assoc; 2011 Apr; 61(4):356-9. PubMed ID: 21465972 [TBL] [Abstract][Full Text] [Related]
7. [Sensitivity of methicillin resistant staphylococci to linezolid and some other antimicrobial agents]. Ertek M; Yazgi H; Aktaş E; Ayyildiz A; Parlak M Mikrobiyol Bul; 2003 Oct; 37(4):235-40. PubMed ID: 14748259 [TBL] [Abstract][Full Text] [Related]
8. Treatment of prosthetic valve infective endocarditis due to multi-resistant Gram-positive bacteria with linezolid. Wareham DW; Abbas H; Karcher AM; Das SS J Infect; 2006 Apr; 52(4):300-4. PubMed ID: 16099052 [TBL] [Abstract][Full Text] [Related]
9. Resistance to linezolid is mediated by the cfr gene in the first report of an outbreak of linezolid-resistant Staphylococcus aureus. Morales G; Picazo JJ; Baos E; Candel FJ; Arribi A; Peláez B; Andrade R; de la Torre MA; Fereres J; Sánchez-García M Clin Infect Dis; 2010 Mar; 50(6):821-5. PubMed ID: 20144045 [TBL] [Abstract][Full Text] [Related]
10. Activity of moxifloxacin against intracellular community-acquired methicillin-resistant Staphylococcus aureus: comparison with clindamycin, linezolid and co-trimoxazole and attempt at defining an intracellular susceptibility breakpoint. Lemaire S; Kosowska-Shick K; Appelbaum PC; Glupczynski Y; Van Bambeke F; Tulkens PM J Antimicrob Chemother; 2011 Mar; 66(3):596-607. PubMed ID: 21186193 [TBL] [Abstract][Full Text] [Related]
11. In vitro susceptibility of staphylococci to linezolid and other antimicrobial agents. Poiată A; Tuchiluş C; Bădicuţ I; Grigore L; Buiuc D Roum Arch Microbiol Immunol; 2002; 61(4):293-9. PubMed ID: 15055263 [TBL] [Abstract][Full Text] [Related]
13. Drugs for MRSA with reduced susceptibility to vancomycin. Med Lett Drugs Ther; 2009 May; 51(1311):36; quiz 37. PubMed ID: 19417720 [No Abstract] [Full Text] [Related]
14. Linezolid-resistant methicillin-resistant Staphylococcus aureus isolated after long-term, repeated use of linezolid. Yoshida K; Shoji H; Hanaki H; Yanagisawa C; Ikeda-Dantsuji Y; Fukuchi K; Adachi M; Niki Y J Infect Chemother; 2009 Dec; 15(6):417-9. PubMed ID: 20012735 [TBL] [Abstract][Full Text] [Related]
15. In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model. Jacqueline C; Caillon J; Le Mabecque V; Miègeville AF; Hamel A; Bugnon D; Ge JY; Potel G Antimicrob Agents Chemother; 2007 Sep; 51(9):3397-400. PubMed ID: 17591849 [TBL] [Abstract][Full Text] [Related]
16. MRSA--too many hurdles to overcome: a study from Central India. Mallick SK; Basak S Trop Doct; 2010 Apr; 40(2):108-10. PubMed ID: 20305109 [TBL] [Abstract][Full Text] [Related]
17. Comparative Efficacy of Ceftaroline with Linezolid against Staphylococcus aureus and Methicillin Resistant Staphylococcus aureus. Hafeez A; Munir T; Rehman S; Najeeb S; Gilani M; Latif M; Ansari M; Saad N J Coll Physicians Surg Pak; 2015 Apr; 25(4):247-9. PubMed ID: 25899187 [TBL] [Abstract][Full Text] [Related]
18. Emergence of linezolid resistance in a methicillin resistant Staphylococcus aureus strain. Hentschke M; Saager B; Horstkotte MA; Scherpe S; Wolters M; Kabisch H; Grosse R; Heisig P; Aepfelbacher M; Rohde H Infection; 2008 Feb; 36(1):85-7. PubMed ID: 18165857 [No Abstract] [Full Text] [Related]
19. Does linezolid modulate lung innate immunity in a murine model of methicillin-resistant Staphylococcus aureus pneumonia? Akinnusi ME; Hattemer A; Gao W; El-Solh AA Crit Care Med; 2011 Aug; 39(8):1944-52. PubMed ID: 21532475 [TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamic comparison of linezolid, teicoplanin and vancomycin against clinical isolates of Staphylococcus aureus and coagulase-negative staphylococci collected from hospitals in Brazil. Kuti JL; Kiffer CR; Mendes CM; Nicolau DP Clin Microbiol Infect; 2008 Feb; 14(2):116-23. PubMed ID: 18076672 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]